Twist Bioscience stock gains 2.32% as CEO weighs WES versus WGS choices

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 2.32% today

Highlights

TWST trades below short-term resistance but maintains a bullish medium- and long-term technical structure.
Momentum indicators present mixed signals with oversold conditions, suggesting potential for a near-term rebound.
Forecast range for the week is $84.00 to $96.00, with 80%+ probability of an upward move and limited downside risk.

The company directed followers to the article for tips on making the right choice. Leproust is also a chemist.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Medium-term uptrend persists as short-term resistance limits upside

TWST is trading at $88.55, positioned below the SMA-20 at $93.25 but above the SMA-50 ($81.11) and well above the SMA-200 ($51.71). This setup signals short-term pressure from sellers, but the medium- and long-term structure remains bullish, with the Ichimoku Kijun at $93.48 acting as immediate resistance. Near-term support is clustered at the SMA-50 ($81.11), with key support further down at the SMA-100 ($66.65). Immediate resistance is marked by the Kijun ($93.48), and key resistance aligns with the SMA-20 ($93.25).

Divergent momentum signals as sellers drive price to weekly lows

Momentum readings are mixed. MACD on D1 shows a strong buy signal, but ADX suggests a sell, highlighting divergence in short-term momentum. RSI is neutral at 49.45 but tilting bearish, while both Stoch RSI and CCI signal oversold conditions and potential for a rebound. BBP is deeply negative at -2.37, indicating seller dominance in intraday trading. TWST has fallen $1.72 (1.91%) over the past week, slipping from a previous close of $90.27. The current price is in the lower part of the weekly range, with weekly volatility standing at 17.41%. The week reflects a steady decline from the high as sellers maintained control.

Bullish reversal favored as oversold signals meet high breakthrough odds

For the coming week, the projected range is $84.00 to $96.00, adjusted for recent volatility and anchored near the middle of the stock’s 52-week spread ($23.30–$105.41). The probability of an upward move is very high (more than 80%), supported by bullish signals on W1: RSI, ADX, MACD, and MA-50 are all in buy territory. The chance of decline is consequently very low. The baseline scenario sees TWST consolidating between support and resistance as oversold readings unwind. The bullish case envisions a breakout above $93.50–$96.00, triggering a move toward the upper end of the short-term range. The bearish scenario would develop only if the price falls below $81.00, exposing deeper support near $66.65, but current signals make this less likely.

Previously it was reported that Twist Bioscience maintained a bullish long-term trend while navigating near-term corrective pressure as investors monitored key technical levels. In the current environment, traders should focus on the prevailing scenario, with particular attention to shifts in momentum that could define the next directional move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.